RxDoctor Payments Data

Kimberly Badinghaus, NP

Nurse Practitioner · Lawrenceburg, INNPI 1801160601

Payments from drug & device makers

$3,442in general payments, 2019–2025

Across 217 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$845
  • Novo Nordisk$442
  • Bayer$256
  • Lilly USA, LLC$210
  • Abbott$198
  • AstraZeneca$191
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$3,428100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,442 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$39,632
Medicare patients
129
Services billed
643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban48$44,160
OzempicSemaglutide28$40,269
MounjaroTirzepatide21$26,036
JardianceEmpagliflozin11$13,494
MyrbetriqMirabegron20$8,841
LinzessLinaclotide15$8,224
Tresiba Flextouch U-100Insulin Degludec15$7,190
InvokanaCanagliflozin12$6,834
Spiriva RespimatTiotropium Bromide11$6,832
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen157$3,427
Albuterol Sulfate HfaAlbuterol Sulfate46$1,829
Fentanyl14$1,629
Atorvastatin Calcium230$1,487
Metoprolol Succinate108$1,361
Levothyroxine Sodium101$1,068

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$145$44,16048 claims
Novo NordiskOzempic$442$40,26928 claims
Lilly USA, LLCMounjaro$210$26,03621 claims
Boehringer IngelheimJardiance, Spiriva Respimat$14$20,32622 claims
Astellas Pharma US IncMyrbetriq$64$8,84120 claims
AbbVieLinzess$845$8,22415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Lawrenceburg

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →